Analyst Ann Hynes from Mizuho continues to endorse Universal Health Services (NYSE: UHS) with a Buy rating, while increasing the price target to $200 from $175. The updated target signifies Mizuho’s optimistic view on the company’s future prospects.
Universal Health Services (UHS) Shows Strong Performance with Positive Price Momentum on March 6, 2024
On March 6, 2024, Universal Health Services (UHS) had a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, UHS showed positive price momentum.
The price of UHS shares increased by $0.90 since the market last closed, representing a 0.52% rise. The stock closed at $175.50, indicating a positive trend for investors. Additionally, the stock remained unchanged in after-hours trading, further solidifying its stability.
Universal Health Services (UHS) Stock Analysis: Strong Financial Performance and Growth Potential
On March 6, 2024, Universal Health Services (UHS) stock showed a steady performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $14.28 billion for the past year, with a fourth-quarter revenue of $3.70 billion.
Net income for UHS was reported at $717.49 million for the past year, with a fourth-quarter net income of $216.31 million.
Earnings per share (EPS) for UHS stood at $10.23 for the past year and $3.16 for the fourth quarter.
Overall, UHS has shown consistent growth in both total revenue and net income over the past year, with a notable increase in net income in the last quarter. The company’s EPS has also shown a positive trend, reflecting strong financial performance.
Investors and analysts may view UHS stock as a stable investment option based on its solid financial performance and consistent growth. The company’s ability to increase net income and EPS, despite flat revenue in the last quarter, indicates resilience and potential for future growth.
